(Q36708990)

15 August 2017

1 reference

title

HIV-neutralizing antibodies: epitope identification and significance for future vaccine (English)

1 reference

15 August 2017

author

Marjorie Robert-Guroff

series ordinal

1

object named as

Robert-Guroff M

1 reference

15 August 2017

language of work or name

1 reference

1 January 1990

1 reference

International Reviews of Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

15-30

1 reference

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Neutralizing antibodies and the course of HIV-induced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Vaccine protection against simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

A formalin-inactivated whole SIV vaccine confers protection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Variable and conserved neutralization antigens of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Extensive variation of human immunodeficiency virus type-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

A molecular clone of HTLV-III with biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Antigenic variation in visna virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

A general model for the transmembrane proteins of HIV and other retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

Complete nucleotide sequence of the AIDS virus, HTLV-III

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

21 January 2018

A chink in HIV's armour?

1 reference

https://api.crossref.org/works/10.3109%2F08830189009061762

10.3109/08830189009061762

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference